Skip to main content
. 2023 Oct 11;18(10):e0292678. doi: 10.1371/journal.pone.0292678

Fig 2. LAT1 expression and prognosis in TCGA BRCA patients.

Fig 2

Prognosis in patients from the TCGA BRCA gene expression dataset. Patients were separated into high (> = 10.47 FPKM) and low (< 10.47 FPKM) LAT1 expression groups, and (A) overall survival and (B) disease–specific survival were observed up to 8605 days after initial treatment. The median for expression level is slightly different from the median stated earlier because patients with indeterminate menopausal status were included in this analysis.